FDA Modernization Act of 2021 [HB-2565]
To amend the Federal Food, Drug, and Cosmetic Act to allow manufacturers and sponsors of a drug to use alternative testing methods to animal testing to investigate the safety and effectiveness of a drug, and for other purposes.
HB-2565: FDA Modernization Act of 2021
Sponsored by: Rep. David Valadao
Referred To The Subcommittee On Health. on 04/16/2021
Gluten in Medicine Disclosure Act of 2021 [HB-2435]
To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug that is intended for human use and contains an ingredient that is derived directly or indirectly from a gluten-containing grain to identify each such ingredient, and for other purposes.
HB-2435: Gluten in Medicine Disclosure Act of 2021
Sponsored by: Rep. Ted Lieu
Referred To The Subcommittee On Health. on 04/09/2021
HR-280: Expressing the sense of the House of Representatives that decades of policies rooted in socialism have stifled United States domestic pharmaceutical drug manufacturing and left the United States exposed to the hostile actions and unfair trade practices of the People's Republic of China.
Sponsored by: Rep. Brian Mast
Referred To The Subcommittee On Health. on 03/29/2021
You have voted HR-280: Expressing the sense of the House of Representatives that decades of policies rooted in socialism have stifled United States domestic pharmaceutical drug manufacturing and left the United States exposed to the hostile actions and unfair trade practices of the People's Republic of China..
Short on Competition Act [S.917]
A bill to allow for expedited approval of generic prescription drugs and temporary importation of prescription drugs in the case of marginally competitive drug markets and drug shortages.
S.917: Short on Competition Act
Sponsored by: Sen. Chuck Grassley
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 03/23/2021
Prescription Drug Price Relief Act of 2021 [S.909]
A bill to significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.
S.909: Prescription Drug Price Relief Act of 2021
Sponsored by: Sen. Cory Booker
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 03/23/2021
Prescription Drug Price Relief Act of 2021 [HB-2148]
To significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.
HB-2148: Prescription Drug Price Relief Act of 2021
Sponsored by: Rep. Barbara Lee
Referred To The Subcommittee On Antitrust, Commercial, And Administrative Law. on 10/19/2021
Alternatives to Animals for Regulatory Fairness Act of 2021 AARF Act of 2021 [HB-1905]
To amend the Federal Food, Drug, and Cosmetic Act to allow the sponsor of a drug to use a non-animal test as an alternative to an animal test for purposes of demonstrating the safety and effectiveness of a drug if such approach satisfies the requirements of the applicable statutes and regulations.
HB-1905: Alternatives to Animals for Regulatory Fairness Act of 2021 AARF Act of 2021
Sponsored by: Rep. Mike Quigley
Referred To The Subcommittee On Health. on 03/17/2021